EP1513951A4 - Mit krebs in verbindung gebrachtes gen als ziel für die chemotherapie - Google Patents

Mit krebs in verbindung gebrachtes gen als ziel für die chemotherapie

Info

Publication number
EP1513951A4
EP1513951A4 EP03726880A EP03726880A EP1513951A4 EP 1513951 A4 EP1513951 A4 EP 1513951A4 EP 03726880 A EP03726880 A EP 03726880A EP 03726880 A EP03726880 A EP 03726880A EP 1513951 A4 EP1513951 A4 EP 1513951A4
Authority
EP
European Patent Office
Prior art keywords
chemotherapy
cancer
target
linked gene
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03726880A
Other languages
English (en)
French (fr)
Other versions
EP1513951A2 (de
Inventor
Zoe Weaver
Reinhard Ebner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clinical Data Inc
Original Assignee
Avalon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avalon Pharmaceuticals Inc filed Critical Avalon Pharmaceuticals Inc
Publication of EP1513951A2 publication Critical patent/EP1513951A2/de
Publication of EP1513951A4 publication Critical patent/EP1513951A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP03726880A 2002-05-16 2003-05-15 Mit krebs in verbindung gebrachtes gen als ziel für die chemotherapie Withdrawn EP1513951A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38091202P 2002-05-16 2002-05-16
US380912P 2002-05-16
PCT/US2003/015313 WO2003097802A2 (en) 2002-05-16 2003-05-15 Cancer-linked gene as target for chemotherapy

Publications (2)

Publication Number Publication Date
EP1513951A2 EP1513951A2 (de) 2005-03-16
EP1513951A4 true EP1513951A4 (de) 2005-12-28

Family

ID=29550036

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03726880A Withdrawn EP1513951A4 (de) 2002-05-16 2003-05-15 Mit krebs in verbindung gebrachtes gen als ziel für die chemotherapie

Country Status (4)

Country Link
EP (1) EP1513951A4 (de)
AU (1) AU2003229293A1 (de)
CA (1) CA2485981A1 (de)
WO (1) WO2003097802A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2537859A1 (de) 2011-06-23 2012-12-26 Université de Mons Moleküle zur spezifischen Bindung pankreatischer Betazellen-Biomarker
US11306144B2 (en) 2017-08-25 2022-04-19 Five Prime Therapeutics, Inc. B7-H4 antibodies and methods of use thereof
BR112020016986A2 (pt) 2018-02-21 2021-03-02 Five Prime Therapeutics, Inc. formulações de anticorpo contra b7-h4
KR20200144094A (ko) 2018-03-02 2020-12-28 파이브 프라임 테라퓨틱스, 인크. B7-h4 항체 및 이의 사용 방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078953A2 (en) * 1999-06-17 2000-12-28 Incyte Genomics, Inc. Human transport proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001271284A1 (en) * 2000-06-07 2001-12-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of pancreatic cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078953A2 (en) * 1999-06-17 2000-12-28 Incyte Genomics, Inc. Human transport proteins

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHIMIENTI FABRICE ET AL: "Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules", DIABETES, vol. 53, no. 9, September 2004 (2004-09-01), pages 2330 - 2337, XP002348398, ISSN: 0012-1797 *
DATABASE EMBL [online] 2 January 2003 (2003-01-02), "Homo sapiens solute carrier family 30 member 8 (SLC30A8) mRNA, complete cds.", XP002348406, retrieved from EBI accession no. EM_PRO:AY117411 Database accession no. AY117411 *
SEVE MICHEL ET AL: "In silico identification and expression of SLC30 family genes: an expressed sequence tag data mining strategy for the characterization of zinc transporters' tissue expression.", BMC GENOMICS [ELECTRONIC RESOURCE], ARTICLE NO. 32, vol. 5, 23 May 2004 (2004-05-23), XP002348397, ISSN: 1471-2164 *

Also Published As

Publication number Publication date
WO2003097802A2 (en) 2003-11-27
CA2485981A1 (en) 2003-11-27
WO2003097802A3 (en) 2004-12-29
EP1513951A2 (de) 2005-03-16
AU2003229293A8 (en) 2003-12-02
AU2003229293A1 (en) 2003-12-02

Similar Documents

Publication Publication Date Title
AU2003245441A8 (en) Cancer-linked gene as target for chemotherapy
AU2003229294A8 (en) Cancer-linked gene as target for chemotherapy
AU2003239969A8 (en) Cancer-linked gene as target for chemotherapy
AU2003249691A8 (en) Cancer-linked gene as target for chemotherapy
AU2003253677A8 (en) Cancer-linked gene as target for chemotherapy
AU2003213743A8 (en) Cancer-linked gene as target for chemotherapy
AU2003229293A8 (en) Cancer-linked gene as target for chemotherapy
AU2003238897A8 (en) Cancer-linked gene as target for chemotherapy
AU2003230611A8 (en) Cancer-linked gene as target for chemotherapy
WO2003104404A3 (en) Cancer-linked gene as target for chemotherapy
AU2003247564A8 (en) Cancer-linked gene as target for chemotherapy
AU2003218014A8 (en) Cancer-linked gene as target for chemotherapy
AU2003243440A8 (en) Cancer-linked gene as target for chemotherapy
AU2003241456A8 (en) Cancer-linked gene as target for chemotherapy
AU2003213672A8 (en) Cancer-linked gene as target for chemotherapy
AU2003241455A8 (en) Cancer-linked gene as target for chemotherapy
AU2003240572A8 (en) Cancer-linked gene as target for chemotherapy
AU2003276643A8 (en) Cancer-linked gene as target for chemotherapy
AU2003251515A8 (en) Cancer-linked gene as target for chemotherapy
AU2003248528A8 (en) Cancer-linked gene as target for chemotherapy
AU2003245536A8 (en) Cancer-linked gene as target for chemotherapy
AU2003245448A8 (en) Cancer-linked gene as target for chemotherapy

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20041125

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20051111

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20071201